Dianthus Therapeutics, Inc. (DNTH) Discusses Interim Responder Analysis and Early Go Decision for CAPTIVATE Trial in CIDP Transcript
Source: SeekingAlpha
2026-03-09 20:47:57 ET
Dianthus Therapeutics, Inc. (DNTH) Discusses Interim Responder Analysis and Early Go Decision for CAPTIVATE Trial in CIDP March 9, 2026 8:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
Dianthus Therapeutics, Inc. (DNTH) Discusses Interim Responder Analysis and Early Go Decision for CAPTIVATE Trial in CIDP Transcript
Dianthus Therapeutics Inc.
NASDAQ: DNTH
DNTH Trading
1.77% G/L:
$83.78 Last:
2,117,975 Volume:
$86.55 Open:
DNTH Latest News
March 10, 2026 10:54:01 pm
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
March 09, 2026 04:01:00 pm
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
DNTH Stock Data
$2,196,597,434
37,892,819
0.47%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
